SurgePays Files 8-K for 'Other Event' on Feb 12, 2024

TL;DR

**SurgePays filed a routine 8-K for an 'Other Event' on Feb 12, showing ongoing compliance.**

AI Summary

SurgePays, Inc. filed an 8-K on February 12, 2024, to report an "Other Event." While the filing itself doesn't detail the specific event, it indicates that the company, incorporated in Nevada with IRS Employer Identification No. 98-0550352, is actively fulfilling its reporting obligations. For investors, this matters because regular and timely SEC filings, even for general 'Other Events,' demonstrate a company's commitment to transparency and compliance, which can build confidence in its operational integrity.

Why It Matters

This filing indicates SurgePays is maintaining its regulatory compliance, which is a basic but important aspect of corporate governance and investor trust.

Risk Assessment

Risk Level: low — This filing is a standard regulatory update and does not disclose any specific adverse events or changes that would increase risk.

Analyst Insight

A smart investor would note this as a routine compliance filing, but would need to look for further details if a specific 'Other Event' was expected or if the company's performance is under scrutiny. This filing alone provides no actionable financial insight.

Key Players & Entities

• SurgePays, Inc. (company) — the registrant filing the 8-K
• Nevada (company) — state of incorporation for SurgePays, Inc.
• 98-0550352 (dollar_amount) — IRS Employer Identification Number for SurgePays, Inc.
• February 12, 2024 (date) — date of earliest event reported and filing date

FAQ

Key Financial Figures

• $0.001 — f the Company's common stock, par value $0.001 per share (the " Offering ") pursuant t
• $5.60 — n stock at the public offering price of $5.60 (the " Over-Allotment Option "). On Feb
• $2.25 m — roceeds to the Company of approximately $2.25 million, before deducting underwriting di
• $17.25 million — ed offering expenses, was approximately $17.25 million. SIGNATURE Pursuant to the requirem

Filing Documents

• form8-k.htm (8-K) — 35KB
• 0001493152-24-005932.txt ( ) — 246KB
• surg-20240212.xsd (EX-101.SCH) — 3KB
• surg-20240212_def.xml (EX-101.DEF) — 26KB
• surg-20240212_lab.xml (EX-101.LAB) — 36KB
• surg-20240212_pre.xml (EX-101.PRE) — 25KB
• form8-k_htm.xml (XML) — 5KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2024 SURGEPAYS, INC. (Exact name of Registrant as specified in its charter) Nevada 001-40992 98-0550352 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3124 Brother Blvd , Suite 104 Bartlett TN 38133 (Address of principal executive offices, including zip code) (901) 302-9587 (Registrant's telephone number, including area code) Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock SURG The Nasdaq Stock Market LLC Common Stock Purchase Warrants SURGW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 8.01. Other Events. As previously reported on a Current Report on Form 8-K, on January 22, 2024, SurgePays, Inc., a Nevada corporation (the " Company ") consummated the sale of 2,678,571 shares (the " Shares ") of the Company's common stock, par value $0.001 per share (the " Offering ") pursuant to an underwriting agreement (the " Underwriting Agreement ") with Titan Partners Group, LLC, a division of American Capital Partners, LLC, as representative of the underwriters named therein (the " Underwriters "). Under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 45 days, to purchase up to an additional 401,785 shares of common stock at the public offering price of $5.60 (the " Over-Allotment Option "). On February 12, 2024, the Company closed on the full Over-Allotment Option resulting in additional gross proceeds to the Company of approximately $2.25 million, before deducting underwriting discounts, commissions and estimated offering expenses. After giving effect to the full exercise of the Overallotment Option, a total of 3,080,356 shares of common stock have been issued and sold in the Offering, and the gross proceeds from the Offering, including the full exercise of the Overallotment Option, before deducting underwriting discounts, commissions and estimated offering expenses, was approximately $17.25 million. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURGEPAYS, INC. Date: February 12, 2024 By: /s/ Kevin Brian Cox Kevin Brian Cox Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR